DSpace Home
→
Browsing by Author

Browsing by Author "Tunca B."

Now showing items 1-10 of 10

BMN 673 (talazoparib): A potent PARP inhibitor for triple negative breast cancer with different genetic profile

Guney Eskiler G; Cecener G; Egeli U; Tunca B. (2019)
In vitro cytotoxic and antiproliferative effects of usnic acid on hormone-dependent breast and prostate cancer cells

Eryilmaz IE; Guney Eskiler G; Egeli U; Yurdacan B; Cecener G; Tunca B. (2018)
Investigation of new treatment option for hepatocellular carcinoma: a combination of sorafenib with usnic acid

Yurdacan B; Egeli U; Guney Eskiler G; Eryilmaz IE; Cecener G; Tunca B. (2019)
Solid lipid nanoparticles: Reversal of tamoxifen resistance in breast cancer

Guney Eskiler G; Cecener G; Dikmen G; Egeli U; Tunca B. (2018)
Synergistic effects of hormone therapy drugs and usnic acid on hormone receptor-positive breast and prostate cancer cells

Guney Eskiler G; Eryilmaz IE; Yurdacan B; Egeli U; Cecener G; Tunca B. (2019)
Synthetically Lethal BMN 673 (Talazoparib) Loaded Solid Lipid Nanoparticles for BRCA1 Mutant Triple Negative Breast Cancer

Guney Eskiler G; Cecener G; Egeli U; Tunca B. (2018)
Talazoparib Loaded Solid Lipid Nanoparticles: Preparation, Characterization and Evaluation of the Therapeutic Efficacy In vitro

Eskiler GG; Cecener G; Dikmen G; Egeli U; Tunca B. (2019)
Talazoparib nanoparticles for overcoming multidrug resistance in triple-negative breast cancer

Guney Eskiler G; Cecener G; Egeli U; Tunca B. (2020)
The role of usnic acid-induced apoptosis and autophagy in hepatocellular carcinoma

Yurdacan B; Egeli U; Eskiler GG; Eryilmaz IE; Cecener G; Tunca B. (2019)
Triple negative breast cancer: new therapeutic approaches and BRCA status

Guney Eskiler G; Cecener G; Egeli U; Tunca B. (2018)

Now showing items 1-10 of 10

| Politika | Rehber | İletişim |

Browse

All of DSpace

Browsing by Author "Tunca B."

Browsing by Author "Tunca B."

Browse

All of DSpace

My Account